CA2784215A1 - Therapeutic combinations of theobromine and an antihistamine - Google Patents

Therapeutic combinations of theobromine and an antihistamine Download PDF

Info

Publication number
CA2784215A1
CA2784215A1 CA2784215A CA2784215A CA2784215A1 CA 2784215 A1 CA2784215 A1 CA 2784215A1 CA 2784215 A CA2784215 A CA 2784215A CA 2784215 A CA2784215 A CA 2784215A CA 2784215 A1 CA2784215 A1 CA 2784215A1
Authority
CA
Canada
Prior art keywords
antihistamine
theobromine
agent
cough
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2784215A
Other languages
English (en)
French (fr)
Inventor
John Brew
Robin Mark Bannister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infirst Healthcare Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of CA2784215A1 publication Critical patent/CA2784215A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA2784215A 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine Abandoned CA2784215A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
GB0921803.3 2009-12-14
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
CA2784215A1 true CA2784215A1 (en) 2011-06-23

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2784215A Abandoned CA2784215A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Country Status (17)

Country Link
EP (1) EP2512472A1 (es)
JP (2) JP2013513652A (es)
CN (1) CN102802625A (es)
AU (1) AU2010332495C1 (es)
BR (1) BR112012014159A8 (es)
CA (1) CA2784215A1 (es)
CO (1) CO6541638A2 (es)
GB (1) GB0921803D0 (es)
IL (1) IL220384A0 (es)
MX (1) MX2012006624A (es)
NZ (1) NZ600267A (es)
PE (1) PE20121538A1 (es)
RU (1) RU2012129675A (es)
SG (2) SG181603A1 (es)
UA (1) UA105827C2 (es)
WO (1) WO2011073647A1 (es)
ZA (1) ZA201204294B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247709B1 (en) * 1986-04-17 1991-01-02 Alza Corporation Chlorpheniramine therapy
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
BRPI0810893A2 (pt) * 2007-04-11 2014-10-29 Alcon Res Ltd Uso de inibidor de tnf-alfa a um anti-histamínico para tratar rinite alérgica e conjuntivite, e composição farmacêutica compreendendo os referidos compostos.

Also Published As

Publication number Publication date
RU2012129675A (ru) 2014-01-27
MX2012006624A (es) 2012-10-05
AU2010332495C1 (en) 2016-02-11
ZA201204294B (en) 2013-02-27
EP2512472A1 (en) 2012-10-24
CN102802625A (zh) 2012-11-28
NZ600267A (en) 2013-07-26
JP6078605B2 (ja) 2017-02-08
BR112012014159A2 (pt) 2017-08-29
GB0921803D0 (en) 2010-01-27
IL220384A0 (en) 2012-08-30
CO6541638A2 (es) 2012-10-16
WO2011073647A1 (en) 2011-06-23
AU2010332495B2 (en) 2015-01-22
PE20121538A1 (es) 2012-12-21
UA105827C2 (uk) 2014-06-25
JP2016040280A (ja) 2016-03-24
BR112012014159A8 (pt) 2017-12-26
JP2013513652A (ja) 2013-04-22
AU2010332495A1 (en) 2012-06-21
SG181603A1 (en) 2012-07-30
SG10201408374WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
AU2010332495C1 (en) Therapeutic combinations of theobromine and an antihistamine
JP6118919B2 (ja) テオブロミンとの薬物組み合わせおよび治療におけるその使用
AU2011294905B2 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
CA2784214C (en) Combination of theobromine with a decongestant and its use for the treatment of cough
CA2780704C (en) Drug combination with theobromine and its use in therapy
AU2015201844B2 (en) Therapeutic Combinations of Theobromine and an Antihistamine
AU2015200654B2 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
AU2015201845B2 (en) Drug combination with theobromine and its use in therapy
AU2015200651B2 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151214

FZDE Discontinued

Effective date: 20191216